1,159
Views
3
CrossRef citations to date
0
Altmetric
Editorials: Cell Cycle Features

NF-κB-regulated ubiquitin-editing enzyme A20 paves the way for infection persistency

, & ORCID Icon
Pages 3-4 | Received 17 Sep 2017, Accepted 27 Sep 2017, Published online: 04 Jan 2018

References

  • Robinson KS, Aw R. The Commonalities in bacterial effector inhibition of apoptosis. Trends Microbiol. 2016;24:665-80. doi:10.1016/j.tim.2016.04.002.
  • Neish A, Naumann M. Microbial-induced immunomodulation by targeting the NF-κB system. Trends Microbiol. 2011;19:596-605. doi:10.1016/j.tim.2011.08.004.
  • Yanai A, Hirata Y, Mitsuno Y, Maeda S, Shibata W, Akanuma M, Yoshida H, Kawabe T, Omata M. Helicobacter pylori induces antiapoptosis through nuclear factor–κB activation. J Infect Dis. 2003;188:1741-51. doi:10.1086/379629.
  • Lim MCC, Maubach G, Sokolova O, Feige MH, Diezko R, Buchbinder J, Backert S, Schluter D, Lavrik IN, Naumann M. Pathogen-induced ubiquitin-editing enzyme A20 bifunctionally shuts off NF-[kappa]B and caspase-8-dependent apoptotic cell death. Cell Death Differ. 2017;24:1621-31. doi:10.1038/cdd.2017.89.
  • Saitoh Y, Hamano A, Mochida K, Kakeya A, Uno M, Tsuruyama E, Ichikawa H, Tokunaga F, Utsunomiya A, Watanabe T, et al. A20 targets caspase-8 and FADD to protect HTLV-I-infected cells. Leukemia. 2016;30:716-27. doi:10.1038/leu.2015.267.
  • Srivastav S, Kar S, Chande AG, Mukhopadhyaya R, Das PK. Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response. J Immunol. 2012;189:924-34. doi:10.4049/jimmunol.1102845.
  • Kumar M, Sahu Sanjaya K, Kumar R, Subuddhi A, Maji Ranjan K, Jana K, Gupta P, Raffetseder J, Lerm M, Ghosh Z, et al. MicroRNA let-7 Modulates the immune response to Mycobacterium tuberculosis infection via control of A20, an inhibitor of the NF-κB pathway. Cell Host Microbe. 2015;17:345-56. doi:10.1016/j.chom.2015.01.007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.